16 October 2026 - Expression Therapeutics Inc, a clinical-stage gene and cell therapy company, announced on Thursday that it has been awarded a National Cancer Institute (NCI) Small Business Innovation Research (SBIR) Phase II grant of USD2,058,885 t...
16 October 2026 - Healthcare technology company Medtronic plc (NYSE:MDT) announced on Thursday that it has completed its separation of MiniMed Group Inc (Nasdaq:MMED).Medtronic elected to exchange all of its remaining interest in MiniMed (a total of ...
16 October 2026 - SenderraRx, an independent specialty pharmacy, announced on Thursday that it has earned reaccreditation in Specialty Pharmacy from the Accreditation Commission for Health Care (ACHC), including a Distinction in Oncology.The Oncology...
15 October 2026 - US-based oncology company Revolution Medicines, Inc. (NASDAQ: RVMD) on Thursday said it has received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use for RASONQUE (daraxonra...
15 October 2026 - Canadian clinical-stage biopharmaceutical company Edesa Biotech, Inc. (NASDAQ: EDSA) said on Thursday it has received US FDA clearance for its Investigational New Drug application for EB06 in vitiligo.The approval allows the company...